Connect® Myeloid Disease Registry

Clinical trial NCT01688011 · TERMINATED

Trial details

NCT number: NCT01688011
Sponsor: Celgene
Status: TERMINATED
Study type: OBSERVATIONAL

Primary Myelofibrosis Myelodysplastic Syndromes Leukemia, Myeloid, Acute

Start date: 2013-12-12
Primary completion: 2024-10-18
Enrollment: 2013

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.